DC has been studied to be pathophysiologically related to RA therapy response by expressing TGF-β, IL-1, IL-6, IL-12, and IL-23, which are essential for proliferation and further maturation of TH1 and TH17 cells [35]. Here, IL6 is linked to rheumatoid arthritis.